首页> 外文期刊>Hemodialysis international >The anticoagulant activity of enoxaparin sodium during on-line hemodiafiltration and conventional hemodialysis.
【24h】

The anticoagulant activity of enoxaparin sodium during on-line hemodiafiltration and conventional hemodialysis.

机译:依诺肝素钠在在线血液透析滤过和常规血液透析中的抗凝活性。

获取原文
获取原文并翻译 | 示例
           

摘要

To study and compare the anticoagulant activity of enoxaparin sodium during on-line hemodiafiltration (OL-HDF) and conventional hemodialysis (C-HD). Enoxaparin was administered as an anticoagulant to 21 hemodialysis patients at the beginning of a single 4-hour OL-HDF session as an intravenous bolus dose of 80 IU/kg [DOSAGE ERROR CORRECTED] On-line hemodiafiltration was performed using a high-flux polyester polymer alloy dialyzer and a total of 18 L replacement fluid (session A). One week later, the study was repeated in the same patients during a single 4-hour session of C-HD using a low-flux polysulfone dialyzer (session B). Blood samples for the measurement of Hb, blood urea and nitrogen (BUN), activated partial thromboplastin time (APTT), and anti-Xa levels were taken before each study session and 5-minute postdialysis. In 13 more patients, the same study was performed during OL-HDF using a high-flux polysulfone dialyzer (session C). No differences were found between sessions A, B, and C when predialysis values for Hb, BUN, APTT, and anti-Xa were compared. The mean postdialysis APTT and anti-Xa values were 32.5+/-3.8 seconds and 0.19+/-0.11 IU/mL, respectively, in session A, 39.0+/-5.0 seconds and 0.71+/-0.17 IU/mL in session B, and 33.8+/-3.1 seconds and 0.35+/-17 IU/mL in session C (A vs. B, P<0.0001, for both parameters, A vs. C, P<0.003 for anti-XA, and B vs. C, P<0.005, for both parameters). The anticoagulant activity of enoxaparin sodium is decreased significantly during a 4-hour OL-HDF session compared with to a similar session of C-HD. The degree of the reduction seems to depend on the dialyzer's membrane.
机译:研究和比较依诺肝素钠在在线血液透析滤过(OL-HDF)和常规血液透析(C-HD)期间的抗凝活性。在单次4小时OL-HDF疗程开始时,依诺肝素作为抗凝剂给予21例血液透析患者,静脉推注剂量为80 IU / kg [已纠正剂量错误]使用高通量聚酯进行在线血液透析滤过聚合物合金透析器和总共18升替代液(A节)。一周后,使用低通量聚砜透析器在单次C-HD的4小时疗程中对同一患者进行了重复研究(B疗程)。在每个研究阶段和透析后5分钟之前,采集血样以测量Hb,血尿素和氮(BUN),活化的部分凝血活酶时间(APTT)和抗Xa水平。在另外13位患者中,使用高通量聚砜透析器在OL-HDF期间进行了相同的研究(C期)。比较Hb,BUN,APTT和抗Xa的透析前值时,在A,B和C段之间未发现差异。在A节中,平均透析后APTT和抗Xa值分别为32.5 +/- 3.8秒和0.19 +/- 0.11 IU / mL,在B节中分别为39.0 +/- 5.0秒和0.71 +/- 0.17 IU / mL ,并且在会话C中为33.8 +/- 3.1秒和0.35 +/- 17 IU / mL(对于两个参数,A vs. B,P <0.0001,A vs. C,抗XA的P <0.003,B vs .C,对于两个参数,P <0.005)。与类似的C-HD疗程相比,在4小时的OL-HDF疗程中依诺肝素钠的抗凝活性显着降低。减少的程度似乎取决于透析器的膜。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号